Renegade Bio
Renegade Bio was founded in 2020, is headquartered in Berkeley, United States, lists 11–50 employees, and has $330K in recorded funding across 2 rounds.
- Headquarters
- Berkeley
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- renegade.bio
- Total Funding
- $330K
- Last Round
- Series AMar 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Renegade Bio was a Berkeley, California-based public benefit corporation providing COVID-19 diagnostic testing services for businesses, schools, and communities. Founded in 2020 by Craig Rouskey, it operated its own CLIA- and CAP-certified lab and developed novel diagnostics leveraging PCR, NGS, and LCMS capabilities. The company closed in March 2024 after four years of operation.
Summary
Renegade Bio is a Biotech company based in Berkeley, United States, founded in 2020. It lists 11–50 employees. It has raised $330K in total across 2 rounds, most recently a Series A round in Mar 2023. Investors include Anzu Partners, FinRebel and SOSV.
Funding History
Mar 2023
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/renegade-bio"><img src="https://indexed.vc/api/badge/company/renegade-bio" alt="Renegade Bio on Indexed.vc" width="260" height="76" /></a>